Pablo G. Legorreta, CEO, Chairman of the Board at Royalty Pharma plc (RPRX), bought 128,500 shares at $28.00 ($280K) on 2020-06-18, disclosed to the SEC on 2020-06-22.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 118,500 | $0 | 0.0% |
| 2 | $28.00 | 10,000 | $280K | 100.0% |
| Total | $2.18 avg | 128,500 | $280K | 100% |
| Filing → |
| RPRX | BUY | 2023-06-13 | $3.0M | — | Filing → |
| RPRX | BUY | 2023-05-24 | $4.8M | — | Filing → |
| RPRX | BUY | 2023-05-17 | $15.4M | — | Filing → |